The Pharmacy Times® Women's Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health conditions that affect women, including gynecological health and maternal health.
Mylan to Acquire Famy Care Businesses to Create a Leading Women's Health Care Franchise
February 2nd 2015Mylan Inc. today announced that it has, through its Indian subsidiary Mylan Laboratories Limited, signed a definitive agreement to acquire certain female health care businesses from Famy Care Limited, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs) for $750 million in cash plus additional contingent payments of up to $50 million.
Read More
Which Atrial Fibrillation Patients Are Most Likely to Misreport Symptoms?
January 30th 2015A primary goal of managing atrial fibrillation is relief of symptoms that include dizziness, fatigue, palpitations, shortness of breath, and chest pain. Yet, it is symptomless in up to one-third of patients.
Read More
Analysis of 12 Studies Links HIV Risk to Contraceptive Use
January 12th 2015Data published in The Lancet Infectious Diseases on Jan. 8 shows that some contraceptives for women may increase the risk of contracting HIV. This information comes from researchers from the University of California Berkeley, who analyzed 12 studies.
Read More
Bisphosphonates May Help Prevent Endometrial Cancer
January 5th 2015Women who take bisphosphonates, which are commonly used to treat osteoporosis and other bone conditions, have about half the risk of developing endometrial cancer as women who do not use the drugs. This study supports other research showing that bisphosphonates may have an anticancer effect.
Read More
Acute Coronary Syndrome in Women: A 10-Year Review
December 6th 2014As pharmacists' ability to tease out more comprehensive information from clinical trials has increased, it has become evident that social and biologic factors interact to produce paradoxical health differences between men and women, especially on cardiovascular outcomes.
Read More